Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the head
Open Access
- 18 May 2007
- journal article
- research article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 57 (2) , 265-268
- https://doi.org/10.1016/j.jaad.2007.01.047
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Imiquimod 5% cream for the treatment of actinic keratosis: Results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histologyJournal of the American Academy of Dermatology, 2004
- Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trialsJournal of the American Academy of Dermatology, 2004
- Short‐course therapy with imiquimod 5% cream for solar keratoses: A randomized controlled trialAustralasian Journal of Dermatology, 2003
- Cycle therapy of actinic keratoses of the face and scalp with 5% topical imiquimod cream: An open-label trialJournal of the American Academy of Dermatology, 2002